| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |